FDA Approves first mesenchymal stem cells

FDA approves first mesenchymal stem cells Therapy for Steroid- Refractory Acute GVHD

The FDA has officially approved the first mesenchymal stormal cell(MSC) therapy to treat steroid-refractory acute graft-versus- host disease(GVHD).